Problems and opportunities to improve diagnosis of asthma and chronic obstructive pulmonary disease in Russia: resolution of advisory board
- Authors: Avdeev S.N.1, Emelyanov A.V.2, Aisanov Z.R.3, Sinopalnikov A.I.4, Fomina D.S.1,5, Nenasheva N.M.4, Leshchenko I.V.6, Zaikova-Khelimskaia I.V.7, Vizel A.A.8, Demko I.V.9, Shaporova N.L.10, Shulzhenko L.V.11,12, Shabanov E.A.13
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Mechnikov North-Western State Medical University
- Pirogov Russian National Research Medical University
- Russian Medical Academy of Continuous Professional Education
- City Clinical Hospital №52
- Ural State Medical University
- Far Eastern State Medical University
- Kazan State Medical University
- Voyno-Yasenetsky Krasnoyarsk Medical University
- Pavlov First Saint Petersburg State Medical University
- Research Institute – Ochapovsky Regional Clinical Hospital №1
- Kuban State Medical University
- Kursk Regional Multidisciplinary Clinical Hospital
- Issue: Vol 94, No 4 (2022)
- Pages: 524-529
- Section: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/108234
- DOI: https://doi.org/10.26442/00403660.2022.04.201487
- ID: 108234
Cite item
Full Text
Abstract
Asthma and chronic obstructive pulmonary disease remain major problems of medicine, and still there is need to improve the level and quality of diagnosis of these diseases. Primary care physicians (general practitioners, therapists) should be involved widely and actively in this process. To simplify the diagnosis, special questionnaires have been developed, they can be used in a real clinical practice. Only this approach will bring statistical data closer to the true prevalence of these diseases and improve quality of their treatment.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Sergey N. Avdeev
Sechenov First Moscow State Medical University (Sechenov University)
Email: emelav@inbox.ru
ORCID iD: 0000-0002-5999-2150
чл.-кор. РАН, д-р мед. наук, проф., зав. каф. пульмонологии, гл. пульмонолог Минздрава России
Russian Federation, MoscowAlexander V. Emelyanov
Mechnikov North-Western State Medical University
Author for correspondence.
Email: emelav@inbox.ru
ORCID iD: 0000-0002-8574-6869
д-р мед. наук, проф., зав. каф. пульмонологии
Russian Federation, Saint PetersburgZaurbek R. Aisanov
Pirogov Russian National Research Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0002-4044-674X
д-р мед. наук, проф. каф. пульмонологии
Russian Federation, MoscowAlexander I. Sinopalnikov
Russian Medical Academy of Continuous Professional Education
Email: emelav@inbox.ru
ORCID iD: 0000-0002-1990-2042
д-р мед. наук, проф., зав. каф. пульмонологии
Russian Federation, MoscowDaria S. Fomina
Sechenov First Moscow State Medical University (Sechenov University); City Clinical Hospital №52
Email: emelav@inbox.ru
ORCID iD: 0000-0002-5083-6637
канд. мед. наук, доц. каф. клинической иммунологии и аллергологии, гл. внештатный специалист аллерголог-иммунолог, рук. Московского городского научно-практического центра аллергологии и иммунологии
Russian Federation, Moscow; MoscowNatalia M. Nenasheva
Russian Medical Academy of Continuous Professional Education
Email: emelav@inbox.ru
ORCID iD: 0000-0002-3162-2510
д-р мед. наук, проф., зав. каф. аллергологии и иммунологии
Russian Federation, MoscowIgor V. Leshchenko
Ural State Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0002-1620-7159
д-р мед. наук, проф. каф. фтизиатрии и пульмонологии
Russian Federation, EkaterinburgIrina V. Zaikova-Khelimskaia
Far Eastern State Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0002-7517-4027
д-р мед. наук, доц., проф. каф. госпитальной терапии
Russian Federation, KhabarovskAlexander A. Vizel
Kazan State Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0001-5028-5276
д-р мед. наук, проф., зав. каф. фтизиопульмонологии
Russian Federation, KazanIrina V. Demko
Voyno-Yasenetsky Krasnoyarsk Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0001-8982-5292
д-р мед. наук, проф.
Russian Federation, KrasnoyarskNataliia L. Shaporova
Pavlov First Saint Petersburg State Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0002-6457-5044
д-р мед. наук, проф., зав. каф. общей врачебной практики (семейной медицины), гл. внештатный специалист по общей врачебной практике (семейной медицине) Ленинградской области
Russian Federation, Saint PetersburgLarisa V. Shulzhenko
Research Institute – Ochapovsky Regional Clinical Hospital №1; Kuban State Medical University
Email: emelav@inbox.ru
ORCID iD: 0000-0002-2110-0970
д-р мед. наук, зав. отд-нием пульмонологии, зав. каф. пульмонологии ФПК и ППС, гл. внештатный пульмонолог ЮФО
Russian Federation, Krasnodar; KrasnodarEvgeny A. Shabanov
Kursk Regional Multidisciplinary Clinical Hospital
Email: emelav@inbox.ru
ORCID iD: 0000-0002-5790-4196
канд. мед. наук, зав. пульмонологическим отд-нием, гл. внештатный пульмонолог Департамента здравоохранения Курской области
Russian Federation, KurskReferences
- Быстрицкая Е.В., Биличенко Т.Н. Заболеваемость, инвалидность и смертность от болезней органов дыхания в Российской Федерации (2015–2019). Пульмонология. 2021;31(5):551-61 [Bystritskaya EV, Bilichenko TN. The morbidity, disability, and mortality associated with respiratory diseases in the Russian Federation (2015–2019). Pulmonologiya. 2021;31(5):551-61 (in Russian)]. doi: 10.18093/0869-0189-2021-31-5-551-561
- Авдеев С.Н., Ненашева Н.М., Жуденков К.В., и др. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации. Пульмонология. 2018;28(3):341-58 [Avdeev SN, Nenasheva NM, Zhudenkov KV, et al. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya. 2018;28(3):341-58 (in Russian)]. doi: 10.18093/0869-0189-2018-28-3-341-358
- Клинические рекомендации «Бронхиальная астма» 2021 г. Российское респираторное общество (РРО). Режим доступа: https://cr.minzdrav.gov.ru/ Ссылка активна на 04.02.2022 [Clinical recommendations “Bronchial asthma” 2021. Russian Respiratory Society (RRS). Available at: https://cr.minzdrav.gov.ru/. Accessed: 04.02.2022 (in Russian)].
- Заболеваемость всего населения России в 2019 году. Статистические материалы. Часть II. ФГБУ «Центральный научно-исследовательский институт организации и информатизации здравоохранения» Минздрава России. М., 2020 [Zabolevaemost' vsego naseleniia Rossii v 2019 godu. Statisticheskie materialy, Chast' II. FGBU “Central'nyi nauchno-issledovatel'skii institut organizatsii i informatizatsii zdravoohraneniia” Minzdrava Rossii. Moscow, 2020 (in Russian)].
- Авдеев С.Н., Айсанов З.Р., Белевский А.С., и др. Пути улучшения диагностики и лечения больных бронхиальной астмой врачами первичного звена. Пульмонология. 2019;29(4):457-67 [Avdeev SN, Aisanov SR, Belevskiy AS, et al. A strategy for improvement in diagnosis and treatment of bronchial asthma in primary care. Pulmonologiya. 2019;29(4):457-67 (in Russian)]. doi: 10.18093/0869-0189-2019-29-4-457-467
- Архипов В.В., Айсанов З.P., Авдеев C.Н. Эффективность комбинаций ингаляционных глюкокортикостероидов и длительно действующих β-агонистов в условиях реальной медицинской практики: результаты многоцентрового кросс-секционного исследования у российских пациентов с бронхиальной астмой. Пульмонология. 2021;31(5):613-26 [Arkhipov VV, Aisanov ZR, Avdeev SN. Effectiveness of inhaled corticosteroids and long-acting β-agonists combinations in real clinical practice: results of a multicenter cross-sectional study in Russian patients with asthma. Pulmonologiya. 2021;31(5):613-26 (in Russian)]. doi: 10.18093/0869-0189-2021-31-5-613-626
- From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2021. Available at: http://www.ginasthma.org. Accessed: 04.02.2022.
- Авдеев С.Н., Айсанов З.Р., Архипов В.В., и др. Роль и значение ингаляционных глюкокортикостероидов у пациентов с хронической обструктивной болезнью легких: современные рекомендации. Заключение совета экспертов. Пульмонология. 2019;29(5):632-6 [Avdeev SA, Aisanov ZR, Arkhipov VV, et al. A role of inhaled corticosteroids in management of patients with chronic obstructive pulmonary disease: current recommendations. Expert panel conclusion. Pulmonologiya. 2019;29(5):632-6 (in Russian)]. doi: 10.18093/0869-0189-2019-29-5-632-636
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. 2019 Report. Available at: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed: 11.01.2022.
- World Health Organization. The top 10 causes of death. Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed: 11.01.2022.
- Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi: 10.7189/jogh.05-020415
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2
- Lopez AD, Shibuya K, Rao C, et al. Obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397-412. doi: 10.1183/09031936.06.00025805
- World Health Organization. Projections of mortality and causes of death, 2015 and 2030. Available at: https://www.who.int/healthinfo/global_burden_disease/projections2015_2030/en/ Accessed: 11.01.2022.
- Andreeva E, Pokhaznikova M, Lebedev A, et al. The Prevalence of Chronic Obstructive Pulmonary Disease by the Global Lung Initiative Equations in North-Western Russia. Respiration. 2016;91(1):43-55. doi: 10.1159/000442887
- Клинические рекомендации «Хроническая обструктивная болезнь легких» 2021 г. Российское респираторное общество (РРО). Режим доступа: https://cr.minzdrav.gov.ru/schema/603_2. Ссылка активна на 29.03.2022 [Clinical guidelines “Chronic obstructive pulmonary disease” 2021 Russian Respiratory Society (RRS). Available at: https://cr.minzdrav.gov.ru/schema/603_2. Accessed: 11.01.2022 (in Russian)].
- Arkhipov V, Arkhipova D, Miravitlles M, et al. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial. Int J Chron Obstruct Pulmon Dis. 2017;12:3255-62. doi: 10.2147/COPD.S142997
- Концевая А.В., Муканеева Д.К., Баланова Ю.А., и др. Экономический ущерб от болезней органов дыхания и хронической обструктивной болезни легких в Российской Федерации в 2016 году. Пульмонология. 2019;29(2):159-66 [Kontsevaya AV, Mukaneyeva DK, Balanova YuA, et al. Economic burden of respiratory diseases and chronic obstructive pulmonary disease in Russian Federation, 2016. Pulmonologiya. 2019;29(2):159-66 (in Russian)]. doi: 10.18093/0869-0189-2019-29-2-159-166
- Mannino DM, Sonia Buist A, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax. 2007;62(3):237-41. doi: 10.1136/thx.2006.068379
- Aaron SD, Tan WC, Bourbeau J, et al. Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction. Am J Respir Crit Care Med. 2017;196(3):306-14. doi: 10.1164/rccm.201612-2531OC
- DeWeerdt S, Grouse L. Chronic Airways Diseases: A Guide for Primary Care Physicians. 2005.
- Decramer M, Cooper CB. Treatment of COPD: the sooner the better? Thorax. 2010;65(9):837-41. doi: 10.1136/thx.2009.133355; PMID: 20805184
- Han MK, Agusti A, Celli BR, et al. From GOLD 0 to Pre-COPD. Am J Respir Crit Care Med. 2021;203(4):414-23. doi: 10.1164/rccm.202008-3328PP
- Kaplan A, Cao H, Fitzgerald JM, et al. Asthma/COPD Differentiation Classification (AC/DC): Machine Learning to Aid Physicians in Diagnosing Asthma, COPD and Asthma-COPD Overlap (ACO). doi: 10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A6285
- Topalovic M, Das N, Burgel PR, et al. Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. Eur Respir J. 2019;53(4):1801660. doi: 10.1183/13993003.01660-2018
- Ramos Hernández C, Núñez Fernández M, Pallares Sanmartín A, et al. Validation of the portable Air-Smart Spirometer. PLoS One. 2018;13(2):e0192789. doi: 10.1371/journal.pone.0192789